Barkin JA, Keihanian T, Barkin JS, Antequera CM, Moshiree B. Preferential usage of rifaximin for the treatment of hydrogen-positive small intestinal bacterial overgrowth. Rev Gastroenterol Peru [nternet]. 24 de julio de 2019 [citado 7 de mayo de 2024];39(2):111-5. isponible en: https://revistagastroperu.com/index.php/rgp/article/view/955